NEWS

Tasly Pharmaceutical Group says JV receives clinical trial approval

Monday, Jul 17, 2017

Tasly Pharmaceutical Group Co Ltd Says 50 percent owned JV received clinical trial approval from China Food and Drug Administration regarding injection for hepatitis B treatment.

 

Source: reuters.com

Other News